{"count": 6, "results": [{"_id": "32738838", "pmid": 32738838, "title": "Study of Diversity of Metformin Related Gastrointestinal Side Effects.", "journal": "J Assoc Physicians India", "authors": ["Saluja M", "Pareek KK", "Swami YK"], "date": "2020-08-01T00:00:00Z", "meta_date_publication": "2020 Aug", "meta_volume": "68", "meta_issue": "8", "meta_pages": "36-38", "score": 50254.336, "text_hl": "INTRODUCTION: @<m>DISEASE_Digestive_System_Diseases</m> @DISEASE_MESH:D004066 @@@Digestive disorders@@@ represent the most common @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ related side-effects in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetics@@@. ", "citations": {"NLM": "Saluja M, Pareek KK, Swami YK. Study of Diversity of Metformin Related Gastrointestinal Side Effects. J Assoc Physicians India. 2020 Aug;68(8):36-38. PMID: 32738838", "BibTeX": "@article{32738838, title={Study of Diversity of Metformin Related Gastrointestinal Side Effects.}, author={Saluja M and Pareek KK and Swami YK}, journal={J Assoc Physicians India}, volume={68}, number={8}, pages={36-38}}"}}, {"_id": "40232293", "pmid": 40232293, "title": "Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis.", "journal": "Expert Opin Drug Saf", "authors": ["Li W", "Wang W"], "date": "2025-04-18T00:00:00Z", "doi": "10.1080/14740338.2025.2494684", "meta_date_publication": "2025 Apr 18", "meta_volume": "", "meta_issue": "", "meta_pages": "1-10", "score": 50250.543, "text_hl": "RESEARCH DESIGN AND METHODS: We utilized the Food and Drug Administration Adverse Event Reporting System (FAERS) to provide an overview of the adverse event landscape tied to the concomitant utilization of ICI and statins or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. RESULTS: Our study reveals significant side effects associated with combining ICIs with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or statins, including @<m>DISEASE_Digestive_System_Diseases</m> @DISEASE_MESH:D004066 @@@gastrointestinal, respiratory, hepatobiliary, and renal disorders@@@. ", "citations": {"NLM": "Li W, Wang W. Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis. Expert Opin Drug Saf. 2025 Apr 18;():1-10. PMID: 40232293", "BibTeX": "@article{40232293, title={Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis.}, author={Li W and Wang W}, journal={Expert Opin Drug Saf}, pages={1-10}}"}}, {"_id": "32150043", "pmid": 32150043, "pmcid": "PMC7439933", "title": "Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation", "journal": "Transplantation", "authors": ["Westerkamp AC", "Fujiyoshi M", "Ottens PJ", "Nijsten MWN", "Touw DJ", "de Meijer VE", "Lisman T", "Leuvenink HGD", "Moshage H", "Berendsen TA", "Porte RJ"], "date": "2020-09-01T00:00:00Z", "doi": "10.1097/TP.0000000000003216", "meta_date_publication": "2020 Sep", "meta_volume": "104", "meta_issue": "9", "meta_pages": "e271-e280", "score": 50250.113, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Preconditioning Did Not Reduce @<m>DISEASE_Digestive_System_Diseases</m> @DISEASE_MESH:D004066 @@@Hepatobiliary Injury@@@ During @DISEASE_Learning_Disabilities @DISEASE_MESH:D007859 @@@NMP@@@", "citations": {"NLM": "Westerkamp AC, Fujiyoshi M, Ottens PJ, Nijsten MWN, Touw DJ, de Meijer VE, Lisman T, Leuvenink HGD, Moshage H, Berendsen TA, Porte RJ. Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation Transplantation. 2020 Sep;104(9):e271-e280. PMID: 32150043", "BibTeX": "@article{32150043, title={Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation}, author={Westerkamp AC and Fujiyoshi M and Ottens PJ and Nijsten MWN and Touw DJ and de Meijer VE and Lisman T and Leuvenink HGD and Moshage H and Berendsen TA and Porte RJ}, journal={Transplantation}, volume={104}, number={9}, pages={e271-e280}}"}}, {"_id": "36464072", "pmid": 36464072, "title": "[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].", "journal": "Ann Pharm Fr", "authors": ["Sakouhi M", "Matmour D", "Belakhdar K", "Kraroubi A"], "date": "2022-12-02T00:00:00Z", "doi": "10.1016/j.pharma.2022.11.013", "meta_date_publication": "2022 Dec 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50244.258, "text_hl": "Five (3.85%) @SPECIES_9606 @@@patients@@@ had a total and lasting intolerance to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MetforminHydrochloride@@@ leading to its discontinuation following persistent @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@. ", "citations": {"NLM": "Sakouhi M, Matmour D, Belakhdar K, Kraroubi A. [Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes]. Ann Pharm Fr. 2022 Dec 2;():. PMID: 36464072", "BibTeX": "@article{36464072, title={[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].}, author={Sakouhi M and Matmour D and Belakhdar K and Kraroubi A}, journal={Ann Pharm Fr}}"}}, {"_id": "21236717", "pmid": 21236717, "title": "Metformin and digestive disorders.", "journal": "Diabetes Metab", "authors": ["Bouchoucha M", "Uzzan B", "Cohen R"], "date": "2011-04-01T00:00:00Z", "doi": "10.1016/j.diabet.2010.11.002", "meta_date_publication": "2011 Apr", "meta_volume": "37", "meta_issue": "2", "meta_pages": "90-6", "score": 50093.863, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Digestive_System_Diseases</m> @DISEASE_MESH:D004066 @@@digestive disorders@@@.", "citations": {"NLM": "Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab. 2011 Apr;37(2):90-6. PMID: 21236717", "BibTeX": "@article{21236717, title={Metformin and digestive disorders.}, author={Bouchoucha M and Uzzan B and Cohen R}, journal={Diabetes Metab}, volume={37}, number={2}, pages={90-6}}"}}, {"_id": "26032654", "pmid": 26032654, "title": "Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.", "journal": "J Clin Pharm Ther", "authors": ["Huang Y", "Sun J", "Wang X", "Tao X", "Wang H", "Tan W"], "date": "2015-08-01T00:00:00Z", "doi": "10.1111/jcpt.12290", "meta_date_publication": "2015 Aug", "meta_volume": "40", "meta_issue": "4", "meta_pages": "461-5", "score": 50044.72, "text_hl": "WHAT IS KNOWN AND OBJECTIVE: @<m>DISEASE_Digestive_System_Diseases</m> @DISEASE_MESH:D004066 @@@Digestive disorders@@@ represent the most common @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ side effects for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Huang Y, Sun J, Wang X, Tao X, Wang H, Tan W. Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes. J Clin Pharm Ther. 2015 Aug;40(4):461-5. PMID: 26032654", "BibTeX": "@article{26032654, title={Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.}, author={Huang Y and Sun J and Wang X and Tao X and Wang H and Tan W}, journal={J Clin Pharm Ther}, volume={40}, number={4}, pages={461-5}}"}}]}